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Abstract
Next generation bioreactors are being developed to generate multiple human cell-based
tissue analogs within the same fluidic system, to better recapitulate the complexity and
interconnection of human physiology [1, 2]. The effective development of these devices
requires a solid understanding of their interconnected fluidics, to predict the transport of
nutrients and waste through the constructs and improve the design accordingly. In this
work, we focus on a specific model of bioreactor, with multiple input/outputs, aimed at gen-
erating osteochondral constructs, i.e., a biphasic construct in which one side is cartilagi-
nous in nature, while the other is osseous. We next develop a general computational
approach to model the microfluidics of a multi-chamber, interconnected system that may
be applied to human-on-chip devices. This objective requires overcoming several chal-
lenges at the level of computational modeling. The main one consists of addressing the
multi-physics nature of the problem that combines free flow in channels with hindered flow
in porous media. Fluid dynamics is also coupled with advection-diffusion-reaction equa-
tions that model the transport of biomolecules throughout the system and their interaction
with living tissues and C constructs. Ultimately, we aim at providing a predictive approach
useful for the general organ-on-chip community. To this end, we have developed a lumped
parameter approach that allows us to analyze the behavior of multi-unit bioreactor systems
with modest computational effort, provided that the behavior of a single unit can be fully
characterized.
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1 Introduction
A number of in vitro approaches have been used over time for high throughput drug screening
or toxicology testing. However, most currently available systems are only partial approxima-
tions of human biology and their predictive capacity is consequently limited. In fact, such sys-
tems are either based on human cell cultures, not capturing the complexity of cell behavior in a
three dimensional (3D) environment, or they are based on animal tissues fragments, 3D in
nature but only partially biosimilar to human tissues and unable to account for interactions
with other organs. To overcome these limitations, next generation bioreactors are being devel-
oped to generate multiple human cell-based tissue analogs within the same fluidic system to
better recapitulate the complexity and interconnection of human physiology. These efforts aim
at creating multi-tissue organ systems (cardiovascular, gastro-intestinal, musculoskeletal, etc.)
that ultimately can be joined in an interconnected human-on-chip device capable of providing
a veritable representation of the body complex response to diseases and potential drug treat-
ments [3–5].
The effective development of these devices requires a solid understanding of their intercon-
nected fluidics, to predict the transport of nutrients and waste through the constructs and
improve the design accordingly. In this work, we have focused on a specific bioreactor with
multiple input/output aimed at generating osteochondral constructs, i.e., a biphasic constructs
in which one side is cartilaginous in nature, while the other is osseous. This bioreactor [1, 6, 7]
represented in Fig 1 has been chosen since it comprises both a dual chamber system to host a
single biphasic tissue construct with distinct fluidics (Fig 1, top), and a set of interconnected
chambers with common fluidics (Fig 1, bottom). Starting from this specific bioreactor, we have
developed a general approach to model the microfluidics of a multi-chamber, interconnected
system that may be applied to human-on-chip devices.
The microphysiological osteochondral bioreactor analyzed in this work is aimed at the
study of osteoarthritis (OA), a major pathology of articular joints, affecting over 33% of the
population over the age of 65 [8]. The hallmark of this disease that affects all tissues in the
joint, is the progressive degeneration of cartilage which begins well before clinical symp-
toms manifest, ultimately requiring joint replacement surgery [9]. The high incidence of
this painful and disabling pathology begs for the understanding of the causes and mecha-
nisms of its development, in order to identify reparative drug therapies to arrest or even
regenerate the damaged tissues and ultimately avoid surgery. A novel strategy in this
respect adopts a tissue engineering approach and the use of bioreactors [1, 7] to generate a
high number of identical in vitro constructs that can replicate the pathogenesis of joint dis-
eases for the identification of therapeutic targets and for drug screening [1, 10–12]. Critical
in this respect is the development of a representative model of the interactions between car-
tilage and other joint tissues and, in particular, with the subchondral bone. In fact, there is
growing evidence of the exchange of nutrients, cytokines, and hormones in vivo between
bone and cartilage. The osteochondral (OC) unit is then conceived as the main target of
OA, to reflect the dynamic cartilage/bone interplay in both health and disease [1, 13–18].
The medium to high throughput system studied in this work, which we call high-through-
put bioreactor (HTB) hereon, is the first of its kind. It hosts in a single chamber a biphasic
construct, with separate fluidics for its cartilaginous and osseous components, effectively
creating a dual-chamber setup (Fig 1) [6, 7]. In this way, cartilage and bone will be in con-
tact and able to signal to each other, while each is exposed to its ideal culture medium. Fur-
thermore, the HTB allows the generation and culture of a high number of identical OC
constructs similar in dimensions to native tissue biopsies [1, 6, 7]. It must be noted that the
physiological functions of the examined tissue are primarily load bearing and force
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transduction, which imply a key role for the extracellular matrix (ECM), also an essential
player in the regulation of cell differentiation, physiology and response to insults [1, 19,
20]. Consequently, a bioreactor that accommodates a significant ECM tissue component to
recapitulate at least some of the physiological aspects of the osteochondral complex
requires a relatively larger volume, in the order of millimeters rather than the hundreds of
micrometers more common in microfluidic systems. To generate a construct that mimics
tissue physiology, the bioreactor chamber is filled with a cell-laden porous polymeric scaf-
fold. Hence, the larger size and the presence of porous scaffold within the insert makes
nutrient perfusion within the device a potential challenge, since to avoid cellular hypoxia
and to obtain adequate tissue development, nutrients must travel a longer path to reach the
inner regions within the bioreactor. In this context, we use computational fluid dynamics
to assess the hydrodynamic properties of the system. Previous works [4, 21–23] evaluated
the fluid mixing and transport of nutrients between chambers in the same unit of a forced
perfusion setup, but to our knowledge there are no similar studies about the interaction of
fluid and porous constructs in a design with more effective fluidics as the one in Fig 1.
Fig 1. Different bioreactor configurations. 1 cell (top left), 1-unit in cross section (top right), 4-units (bottom left)
and 96-units. (bottom right).
doi:10.1371/journal.pone.0162774.g001
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Furthermore, to achieve a high-throughput drug screening system, single bioreactor dual-
chambers (bioreactor unit) have been connected and combined in a multi-unit system, orga-
nized in sequential and parallel rows (Fig 1). In the 96 wells design presented in Fig 1, individ-
ual units are connected only in series, 8 at a time as this design is best suited for drug or
toxicological screening; to asses for instance a dose response, each array of 8 units can be sub-
jected to a different concentration of the compound under examination. “In parallel” connec-
tion, although possible, has not been envisioned. The constructs in each row are meant as
replicates for multiple endpoint testing (e.g., histology, PCR, etc.). A further challenge is then
to guarantee that the tissue constructs in the downstream chambers receive the appropriate
amount of nutrients from the fluid that has perfused the units upstream. In other words, not
only a dual-chamber bioreactor, but also a multi-unit array shall be analyzed.
The specific objective of this work is to develop a methodology to characterize the flow and
transport in a HTB by means of a computational modeling approach, combining distributed
and lumped parameter models. In particular, we have assessed the degree of perfusion and
mixing of nutrients in each region of the device, evaluating the effect of different scaffold types.
The computational model was then used to compare two different engineered constructs, a
hydrogel (methacrylated gelatin, GelMA [6, 24]) and a porous polymeric scaffold (poly-L-lac-
tate, PLLA)[25]. The first one features very small pore size and is solute permeable, the second
one shows larger pore size and is impenetrable to fluid and nutrients.
Performing such simulations requires overcoming several challenges at the level of
computational modeling. The main one consists of addressing the multi-physics nature of
the problem that combines free flow in channels with hindered flow in porous media. Fluid
dynamics is then coupled with advection-diffusion-reaction equations that model the trans-
port of biomolecules throughout the system and their interaction with living tissue. Besides
these modeling challenges, the complex configuration of the bioreactor poses significant
difficulties in building the CADmodel and discretizing its parts with a computational mesh
suitable for the application of a numerical scheme. These issues can be solved using an in-
house-made software that incorporates state-of-the-art efficient algorithms for the approxi-
mation of partial differential equations. Although this approach is viable, it entails signifi-
cant costs in terms of man-hours for the implementation and validation of the new
software. For this reason, we have adopted here a commercial platform, ANSYS (ANSYS
Inc., Canonsburg, PA), which features advanced multi-physics simulation capabilities.
Another challenging aspect of this work is then to stretch the limits of the ANSYS platform
to address the complex problem at hand. Ultimately, our aim is to provide a predictive
approach useful for the general organ-on-chip community. To this end, we have developed
a lumped parameter approach that allows us to analyze the behavior of multi-unit bioreac-
tor systems with a modest computational effort, provided that the behavior of a single unit
could be fully characterized. If the linearity conditions are satisfied, this computational
methodology is independent from the specific osteochondral nature of the biological system
being studied. Our approach simply describes a network of interconnected multi-chamber
units. Consequently, we believe that our approach can be directly applied to predict the
flow and transport of a generic human-on-chip setup, even those comprising multiple phys-
iological systems (e.g., a liver model connected to a kidney model, connected to a bone
model, etc.) with single or multi-chamber units.
2 Models and Methods
Exploiting the commercial platform ANSYS (ANSYS Inc., Canonsburg, PA), we have devel-
oped a CADmodel of the bioreactor and we have used it to simulate flow and transport
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phenomena in the system. The steps to achieve a realistic simulation of the fluid and transport
within the bioreactor are detailed below.
2.1 CAD model
The 3D CADmodel of the bioreactor was created using ANSYS ICEM CFD v.15.0 (ANSYS
Inc.) CADmodeler. We have considered a row of 4-units connected in series (see Fig 1).
Each unit has the same configuration, specifically designed to grow a construct that com-
bines cartilage and bone, and comprises the following parts: two inlets and two outlets con-
sisting of cylindrical channels, to guarantee the circulation of fluid from the upstream units
to the downstream ones. Each inlet/outlet channel is characterized by a length (L) of 5.3
mm and an inner diameter (d) of 1 mm. The perforated cylindrical insert that holds the
scaffold in place is 8.5 mm high and 3.75 mm wide. Each bioreactor chamber is sealed by an
upper cap and by two O-rings (see Fig 1). Forthcoming extensions of this study will con-
sider rows of 8 bioreactor units. By aligning 12 parallel lines of these rows, one obtains a
plate of 96-units, which is a realistic prototype of high-throughput bioreactor for drug
screening.
2.2 Flow
The bioreactor features the combination of free flow for the inlets, outlets, and the outer
chambers with porous media flow for the inner culture chamber (insert). In each region,
we assume that the flow is incompressible. For momentum balance, our approach employs a
general equation that encompasses the nature of both types of flow, and we will switch
between them by suitably tuning the problem parameters in each region. This equation
has the structure of Brinkman equation for flow in porous media, because it combines
viscous terms, such as in Stokes, with friction terms, such as in Darcy. To model free flow,
a convective term, which plays a significant role in case of high Reynolds regimes, was
added. Static conditions are also assumed. Then, the momentum balance equation reads as
follows:
∆  rU ⇥ UÖ Ü   ∆  m Ö ∆UáÖ ∆U ÜTÜ    à   m
Kperm
U   ∆p 8x 2 Ωc up [Ωcdown [Ωscaffold Ö1Ü
where U denotes the velocity vector field (Uf and Us denote the restriction of the velocity
field to the free fluid and porous medium, respectively), p the hydrostatic pressure, ρ e μ are
the fluid viscosity and density respectively, and Kperm the hydraulic conductivity of the
porous medium (for the free flow regions we set Kperm!1). For the partition of the biore-
actor into sub-regions, we refer to Fig 2. We assume that the culture medium that perfuses
the bioreactor is comparable to water (ρ = 999,97 kg/m3 μ = 0,001 Pa s) since the dissolved
nutrients and other chemical species are relatively dilute.
For the definition of boundary conditions, we partition the bioreactor surface as illustrated
in Fig 2. At the bioreactor inlet, (Γc_up,in e Γc_down,in), a given flow rate is applied through the
enforcement of a flat velocity profile on the inflow sections; a no-slip condition is adopted on
the surfaces that separate the free fluid and the porous medium from the bioreactor walls
(Gc up; Gcdown e Gscaffold), which have been assumed to be rigid walls. At the outlet, (Γc_up,out e
Γc_down,out) we have set a uniform normal stress field equal to the atmospheric pressure, namely
σf   n = 0, where σf à
∆  Öm Ö ∆UáÖ ∆U ÜTÜÜ   ∆p is the Cauchy stress in the fluid. Given the
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previous modeling choices, the flow problem becomes
∆ U à 0 8x 2 Ωc up [Ωc down [Ωscaffold
∆ ÖrU ⇥ U Ü   ∆ Öm Ö ∆U á Ö ∆U ÜTÜÜ à   m
Kperm
U   ∆p 8x 2 Ωc up [ Ωc down [Ωscaffold
QÖrÜ à  Q 8x 2 Gc up;in [ Gc down;in
p à 0 8x 2 Gc up;out [ Gc down;out
U à 0 8x 2 Gc up [ Gc down [ Gscaffold
Uf à Us 8x 2 Gfluid porous
σ f  n à σs n 8x 2 Gfluid porous
Ö2Ü
2.3 Mass transport
An important part of this study consists of modeling the transport of bio-molecules dissolved
in the culture media that perfuse the bioreactor. In particular, we focus on oxygen, fundamental
to guarantee cell survival.However, the model is general and has been used to describe the
transport of glucose and proteins, as it will be reported in forthcoming works.
Since all solutes are diluted, they are modeled as passively transported by the culture media.
Their governing equations have been formulated in terms of volumetric concentrations measured
Fig 2. Representation of the bioreactor. Free fluid regions are visualized in grey, the porous medium is red
(top). For the localization of boundary surfaces,Ω and Г indicate volume and surface, respectively (bottom).
doi:10.1371/journal.pone.0162774.g002
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in [mg/ml]. The symbol C denotes the solute concentration, D the diffusion coefficient for the spe-
cific biomolecule and the subscripts f and s indicate the fluid and the porous medium (scaffold),
respectively. Therefore the equation describing the biomolecules’ transport in the fluid phase is:
∆  Ö Df
∆Cf á UCf Ü à 0 8 x 2 Ωc up [Ωc down Ö3Ü
For the porous medium, namely the scaffold region, we assume that fluid and solid phases
coexist.We denote with Cs,s and Cs,f the volumetric concentration of biomolecules in the solid
and in the fluid phase of the scaffold, respectively. Denoting with γ the porosity of the scaffold
(complement to unity of the solid phase, i.e. for the free flow regions we set γ = 1), the volumet-
ric concentration of biomolecules in the porous medium is given by the following weighted
average Cs = γCs,f + (1 − γ)Cs,s. Then, following the theory of mixtures, the governing equations
for biomolecules concentration in the porous medium read as follows:
∆  Ö Ds;s
∆Ö1  gÜCs;s á Ö1  gÜUCs;sÜ á Ö1  gÜSá tIADÖCs;s   Cs;f Ü à 0;
∆  Ö Ds;f
∆
gCs;f á UgCs;f Ü á gSá tIADÖCs;f   Cs;sÜ à 0 8 x 2 Ωscaffold:
Ö4Ü
This model assumes that both the fluid and the solid phases in the porous medium are per-
meable to biomolecules. The mass transfer coefficient from the fluid to the solid phase in the
porous medium is τ, while IAD is the interface area density of the surface separating the two
phases. As a result, the term τIAD(Cs,s − Cs,f) represents the flux exchanged between the two
phases of the porous medium. The symbol S denotes the source term representing the con-
sumption of nutrients by living cells disseminated into the scaffold. For this reason, it is usually
a function (linear or nonlinear) of the nutrient concentration.We will discuss the constitutive
models for the parameters S,τ,IAD in the next section.
At the inlet boundaries (Γc_up,in e Γc_down,in) a known concentration has been imposed,
using independent values on each inlet section. A homogeneousNeumann condition ∆Cf  
n = 0 has been adopted on the bioreactor wall and outlets (Gc up; Gc down; Gc up;out e Gc down;out).
In fact, the wall is considered impermeable to nourishments and their flux in the direction nor-
mal to the outlets is assumed equal to zero. Moreover, conservation of concentrations Cf = Cs
and of biomolecules flux −Df
∆  Cfn = −Ds ∆  Csn have been applied at the interface between
fluid and porous media (Γfluid–porous). As a result, the concentration of oxygen is determined by
the following problem:
∆ Ö Ds;f
∆γCs;f á UγCs;f Ü á γSá τIADÖCs;f   Cs;sÜ à 0 8x 2 Ωscaffold
∆ Ö Ds;f
∆γCs;f á UγCs;f Ü á γSá τIADÖCs;f   Cs;sÜ à 0 8x 2 Ωscaffold
∆ Ö Df
∆Cf á UCf Ü à 0 8x 2 Ωc up [ Ωc down
Cfà  C1 8x 2 Γc up;in
Cfà  C2 8x 2 Γc down;in
∆Cf  n à 0 8x 2 Γc up;out [ Γc down;out
∆Cf  n à 0 8x 2 Γc up [ Γc down
Cf à γCs;f á Ö1  γÜCs;s 8x 2 Γfluid porous
 γDf
∆Cf  n à  Ds
∆ÖγCs;f Ü n 8x 2 Γfluid porous
 Ö1  γÜDf
∆Cf  n à  Ds
∆ÖÖ1  γÜCs;sÜ n 8x 2 Γfluid porous
Ö5Ü
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2.4 Model parameters and constitutive laws
2.4.1 Model parameters for the flowmodel. First, the characteristic Reynolds number of
the flow in the bioreactor was determined from the following definition,
Re à vDr
m
à 4
pD
rvpD2
4m
à 4
pD
r Q
m
Ö6Ü
whereD is the inlet diameter of 1mm, ρ = 999,97 Kg/m3 and μ = 0,001 Pa   s are the fluid den-
sity and dynamic viscosity, respectively,  Q is the inlet flow rate into each chamber, equal to 1
ml/day. A Re⌧ 0,01, was found thus confirming that the assumption of laminar flow is accu-
rately verified. As a consequence, the inertial (and nonlinear) term in the momentum equation,
namely rU ⇥ U , can be neglected and the flow model turns out to be a set of linear equations.
This will be the key property for the later derivation of a surrogate of the flow model, which is
only based on algebraic equations consequently featuring a negligible computational cost.
Another parameter, essential to determining the flow in the porous medium is the (intrin-
sic) permeabilityKperm that is determined by the microscopic structure of the scaffold, quanti-
fied by the porosity (γ), the tortuosity, etc. In the case of materials featuring an anisotropic
structure, permeability is a tensor quantity. Here, since the scaffolds under consideration are
isotropic, it becomes a scalar parameter. In what follows, we will consider two types of scaf-
folds, one made out of methacrylated gelatin (GelMA) and the other consisting of a poly-L-lac-
tate (PLLA) foam. The porosity and permeability of the latter have been estimated via Boyle’s
pycnometer and scanning electronmicroscopy (SEM) analysis. Data for GelMA are scarce in
literature. However, for tissue engineering it is used as a surrogate material to mimic the extra-
cellular matrix of cartilage; hence, we initialized the model for the bioreactor configuration
using data that have been previously measured for native cartilage [26]. In both cases, the val-
ues for porosity and permeability are reported in Table 1.
2.4.2 Model Parameters and constitutive laws for mass transport. Inlet concentrations
for oxygen are 3.15 e-3 [mg/ml] and 7.2 e-3 [mg/ml] for the upper and lower chamber, respec-
tively. We observe that the oxygen supply of the upper chamber falls within the range of hyp-
oxic conditions, compatible with the biological need of the chondral tissue, while the lower
chamber, where bone is developed, is kept under normoxic conditions. These different envi-
ronments are aimed at supporting stem cell differentiation into a chondral and osseous pheno-
type, respectively [27]. The diffusion coefficientwas obtained from previously published
studies [28].
For the exchange of biomolecules between fluid and solid phases within the scaffold, the
coefficients τ,IADmust be calculated. To this purpose, we model the porous medium as a peri-
odic structure whose unit can be idealized as a cube containing a hollow sphere, namely the
pore, as illustrated in Fig 3.
Although this configuration is incompatible with the flow through the pore, as it is
completely closed, it is adequate for modelingmass transfer between the solid and the fluid
phases of the porous medium. According to this model, we estimate the value of the interface
area density (IAD), which only depends on the configuration of the unit. Let Se_s = 4πR2 and
Si_s = 4π(R−δ)2 be the external and internal pore surface, respectively, and let Vc be the total
Table 1. Porosity and permeability values used for GelMA and PLLA scaffolds.
GelMA scaffold PLLA scaffold
Porosity 0.8 0.93
Permeability [m^2] 1 e-16[20] 3.23384e-09
doi:10.1371/journal.pone.0162774.t001
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volume of the unit. Then the interface area density is defined as:
IAD à Se s á Si s
Vc
Ö7Ü
To estimate the mass transfer coefficient,we assume that at the pore scale mass transfer is
dominated by diffusion in the solid phase. As a consequence, the Sherwoodnumber magnitude
turns out to be in the range of unity. Exploiting this assumption, we have
1 à Sh à td
Ds;s
Ö8Ü
where τ is the mass transfer coefficient and d is the pore diameter. As a result, we obtain,
t à Ds;s
d
Ö9Ü
We observe that GelMA and PLLA have different behaviors with respect to mass transfer
and interface area density. GelMA scaffold has homogeneous properties, namely the pore
radius is uniform everywhere and equal to R = 9.77205 e-6[m] with a thickness δ = 10%R. The
GelMAmatrix is permeable to solutes, as shown by the positive diffusion coefficientsDs,s
reported in Table 2. The PLLA scaffold is substantially different because it is impermeable to
solutes. As a result, the mass transfer coefficient is necessarily null. Since the exchange between
Fig 3. Representative SEM micrograph of the PLLA scaffold and microscopic model of the scaffold
pores for the quantification of the exchange between fluid and solid constituents of the porous
matrix.
doi:10.1371/journal.pone.0162774.g003
Table 2. Oxygen parameters adopted for GelMA and PLLA scaffolds.
GelMA PLLA
Df = Ds,f 2.1 x10-9 [m2/s] 2.1 x10-9 [m2/s]
Ds,s 4.5 x10-10 [m2/s] 0
τ 0.230248 e-5[21] [m s^-1] 0
IAD 2.9094 e5 [m^-1] 3.8924 e4
vmax 1.15 10−17 [mol/cell s] 1.15 10−17 [mol/cell s]
Nv 1.12 106 [cell/ml] 1.12 106 [cell/ml]
Cs 168.98 10
−9 [mol/cl] 168.98 10−9 [mol/cl]
doi:10.1371/journal.pone.0162774.t002
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solid and fluid phases in the porous medium is modeled by terms τIAD(Cs,s−Cs,f), we notice
that the interface area density does not affect the model.
In order to complete the mass transport model, we introduced the term S, to account for
both catabolite production and metabolite consumption in cell metabolism.Given the impor-
tance of maintaining cell viability by ensuring sufficient nutrients supply, we focus in particular
on metabolite consumption, for which studying transport of oxygen is ideal. Cells are assumed
to be confined in the porous scaffold and consumption of nutrients, S(Cs), is expected to be
proportional to their availability, namely S(Cs) = S(γCs,f + (1−γ)Cs,s). Different models can be
adopted for this function, either linear or nonlinear. In the former case we set S(Cs) = rCs,
where r is a constant parameter determined according to the following balance law:
r    C à Vmax   Nv Ö10Ü
where  C is a reference concentration for each solute, measured in [mol/ml],Vmax is the maximal
consumption rate for the considered nutrient and for a specific cell phenotype, quantified in
[mol/cell s], andNv is the average volumetric cell density in the scaffold, measured in [cells/ml].
The main limitation of this model is that it does not guarantee any upper bound for nutrient con-
sumption rate. The more nutrients are available, the more they are metabolized.This approach
can be improved using a Michaelis-Menten description of cell metabolism [29], which introduces
saturation of the consumption rate, according to the following function:
rÖCsÜ à
VmaxCs
Km á Cs
Ö11Ü
whereKm is theMichaelis-Menten constant, equal to the concentration at which the consump-
tion rate reaches 50% of the maximal value. As a result, the consumption term turns out to be a
nonlinear function, namely
SÖCsÜ à rÖCsÜCs Ö12Ü
We observe that for small nutrient concentrations the linear and the Michaelis-Menten
models behave similarly, whereas the latter provides a better estimate of metabolic consump-
tion in case of abundance of nutrients.
2.5 Computational solvers
The commercial code ANSYS CFX v.13.0 was used to carry out the fluid dynamic and mass
transport simulations. The spatial discretization consists of a cell based finite volume method.
From the computational standpoint, the main challenge of this study consists in solving a
fluid-porous interaction problem that involves coupled flow and mass transport. A fully cou-
pled strategy has been adopted, namely all the equations are solved simultaneously through a
monolithic linear system that embraces all the degrees of freedom.
More precisely, the Laplace operator in the fluidmomentum and oxygen transport equa-
tions is approximated by a centered scheme, while the convective terms have been discretized
by means of an upwind method. The convective term in the Navier-Stokes equations is linear-
ized by Picard iterations (equivalent to a fictitious time stepping method with semi-implicit
treatment of ∆  ÖrU ⇥ U Ü) (“ANSYS CFX-Solver Theory Guide”, ANSYS Inc., 2010). The
pressure variable in the Navier-Stokes equations is evaluated at the same nodes of the velocity
field.
The system is then solved using an algebraic multigridmethod exploiting incomplete LU
factorization as smoother. Numerical simulations have been performed on parallel CPUs using
a quad-socket 12-Core AMDMagny Cours CPU, 128 GB RAM at University of Pittsburgh.
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Convergence criteria were set to 10−6 for the normalized residuals of the global linear system of
equations.
To ease the convergence of the algebraic solver, it turned out to be extremely helpful to
neglect the contribution of streamline diffusion in the mass transport model, accounting only
for the cross-wind component of the diffusion operator. From the modeling standpoint, this
approximation is justified since the Péclet number characterizingmass transport in the ducts
and in the scaffold of the bioreactor is larger than unity. More precisely, we define the Péclet
number as follows
Pe à a
 U
D
Ö13Ü
where a is the characteristic length of diffusion,  U is the characteristic fluid velocity and D is
the diffusion coefficient of the nutrient in the fluid (water). The Péclet number has been calcu-
lated for two sets of parameters, the first one identifying flow and mass transport in the pores
of the insert (a = 9.77205 e-6 m,  U = 1.546e-3 m/s, D = 2.9e-9 m2/s) and the second one the
flow in the chambers that will hold the scaffold (a = 5 e-4 [m],  U = 1.473e-5 [m/s], D = 2.9e-9
[m2/s]). For the insert we obtained Pe = 2.5, while for the chambers Pe = 5.2.
Domain discretization is a crucial phase in the computational model set up to ensure an
accurate description of the investigated phenomena as well as reasonable computational time
and costs. The geometrical features of the bioreactors span from 8.5 mm (height of the scaf-
fold), to 1 mm (inlet/outlet channel inner diameter), to 0.25 mm (radius of the pores). The
final mesh consists of 735658 and 550226 tetrahedral elements for the GelMA and the PLLA
case, respectively, with a minimum dimension of the elements of 0.1 mm and a maximum of
0.25 mm. This discretization is suitable for the fluid dynamics model, because, as previously
stated, the Reynold’s number results smaller than 0.01, and consequently the boundary layers
can be considered fully developed. The fluid dynamics simulations in single array are per-
formed with moderate computational effort (about 7 minutes on CPUs using a quad-socket
12-Core AMDMagny Cours CPU, 128 GB RAM). A numerical test that uses a coarser mesh
consisting of 443740 and 242236 elements, respectively, confirms that the results obtained with
the finer discretization are insensitive to the mesh size.
3 Lumped Parameter Models of HTB
Although in-silico analysis is rightfully considered a cost efficient approach with respect to
experimental investigation, section 2.3 illustrates that the development of a computational
model of the bioreactor is a challenging task, because of the significant amount of work-hours
required to define a detailed CADmodel and the considerable computational efforts involved
with the definition of a computational mesh and with the solution of the discrete equations.
When using numerical tools in the design or optimization of the bioreactor configuration
and working conditions, it is essential to minimize the cost of running simulations for different
sets of design parameters. The scientific computing community is well aware of this critical
aspect of the approach and has recently made great progress in developing strategies to synthe-
size surrogate models that replace the brute force simulation approach with much less compu-
tational costs. We have mentioned a list of a few examples related to bioengineering [30–36],
among many others.
Surrogate or reducedmodels are based on much simpler mathematical operators than par-
tial differential equations. For steady problems, they may consist of algebraic equations, or
ordinary differential equations to capture time dependent phenomena. Such models are often
called lumped parameter models, because they synthesize into a small number of coefficients
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the behavior of spatially dependent functions, solutions of partial differential equations, a.k.a.
distributed parameter models.
The aim of this section is to derive a set of lumped parameter models describing flow and
mass transport in the bioreactor fulfilling two objectives:
1. To determine the change of quantitative outputs when the input data are varied, for a fixed
single or multi-chamber configuration,
2. To determine the change of quantitative outputs when the number of chambers in the array
is varied.
3.1 Lumped parameter model for a fixed HTB configuration
We aim to develop an input-output relation between parameters of the model and observed
quantities of interest. Because of the linearity of the flowmodel, motivated by low Reynolds
numbers, this relation is a linear operator that can be characterized by a limited number of sim-
ulations. The number of required simulations depends on the dimension of the input/output
parameter space.
To illustrate the derivation of a lumped parameter model, we consider an example that will
be later used for the bioreactor design. In particular, we analyze the flow split at the outlet of
the bioreactor chambers for prescribed values of the inlet flow rates.
Let us consider the velocity fieldsUi; i à 1; 2 defined by fixing unit flow rates at each inlet
of the bioreactor,
  ∆  ÖmÖ ∆Ui á Ö
∆UiÜTÜÜ à  
m
Kperm
U i  
∆pi 8x 2 Ωc up [Ωc down [Ωscaffold
∆  Ui à 0 8x 2 Ωc up [Ωc down [Ωscaffold
Ui à 1 8x 2 Gin;i; i à 1; 2
sÖU ; pÜ   n à 0 8x 2 Gout;i; i à 1; 2
Ö14Ü
Since the flowmodel is linear, the velocity and pressure fieldsU ; p corresponding to any
combination of the inlet flow rates, denoted as Qin1 and Qin2 respectively, can be represented as
a linear combination of solutionsUi; pi
U à Qin1
A1
U 1 á
Qin2
A2
U 2; p à
Qin1
A1
p1 á
Qin2
A2
p2 Ö15Ü
Since we are interested in the quantification of the outflow rates, we calculate
Qout;i à
Z
Gout;i
U   ndx à Qin;1
Z
Gout;i
U 1   ndx
zÇÇÇÇÇÇÇÇÇ}|ÇÇÇÇÇÇÇÇÇ{mi;1
á Qin;2
Z
Gout;i
U 2   ndx
zÇÇÇÇÇÇÇÇÇ}|ÇÇÇÇÇÇÇÇÇ{mi;2
à
à Qin;1  mi;1 á Qin;2  mi;2 Ö16Ü
As a result, we have identified the following input-output algebraic relation between inlet
and outlet flow rates
Qout;1
Qout;2
     
      à m1;1 m1;2m2;1 m2;2
     
        Qin;1Qin;2
     
      i:e: Qout;1Qout;2
     
      à M Qin;1Qin;2
     
      M à m1;1 m1;2m2;1 m2;2
     
      Ö17Ü
that represents the lumped parameter model we were looking for. We note that the operator
(matrix)M depends on the bioreactor geometric design.
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This approach can be extended to the mass transport problem, provided that the model
adopted for consumption of nutrients is linear, namely S(Cs) = rCs. In this case, we denote with
di the solution of Eq 5 obtained setting  Ci à Cin;i à 1 and  Cj6ài à Cin;i 6àj à 0. Then, any solution
Cf of the mass transport problem can be expressed as
Cf à Cin;1d1 á Cin;2d2 Ö18Ü
Let Cout,1,Cout,2 be the nutrient concentration on the upper and lower outlets respectively
and for simplicity of notation let us define
di;1 à dijGout;up; di;2 à dijGout;down Ö19Ü
Then, because of the linearity of the mass transport model we obtain
Cout;i à Cin;1   d1;1 á Cin;2   d2;1 Ö20Ü
that can be translated in the following vector form,
Cout à D   Cin ; Cout à
Cout;1
Cout;2
     
     ; Cin à Cin;1Cin;2
     
     ; D à d1;1 d1;2d2;1 d2;2
     
      Ö21Ü
3.2 Lumped parameter model for variable bioreactor configurations
Here we focus on the problem of determining a lumped parameter model for a sequence of bio-
reactor units, when the solution for 1-unit is known. From the methodological standpoint, this
problem is more challenging than the one of characterizing the lumped parameter model for
one bioreactor unit, because partial differential equations are not linear with respect to the con-
figuration of the domain. In other words, the solution of an n-unit bioreactor is not the super-
position of n solutions of a single unit configuration.
Another strategy for determining a lumped parameter model of a multi-unit configura-
tion emerges observing that units are combined in sequence (see Fig 4). Consequently, we
conjecture that the behavior of the n-unit bioreactor is the composition of n-unit models. As
an example, for a sequence of two units we posit that the input/output relation for flow rates
is
Q0out2
Q0out1
     
      à eM Qin2Qin1
     
     ; Q
0
out2
Q0out1
     
      à eM1 Q
0
in2
Q0 in1
     
     ; Q
0
in2
Q0 in1
     
      à eM 2 Qin2Qin1
     
      Ö22Ü
Owing to the similar design of the upper and lower chambers, the resistance to flow of the
fluid entering from the upper and lower inlets is comparable. As a result, the following property
is valid at any junction between two adjacent bioreactor units,
sÖU ; pÜ   njG1 à sÖU ; pÜ   njG2 Ö23Ü
It shows that equal normal stresses are applied at the intermediate section of a 2-unit biore-
actor. Since these are the boundary conditions applied at the outlet of our model for an individ-
ual unit it means that any unit in a row functions as an individual one. As a result, we conclude
that eM1 Å M; eM2 à M Ö24Ü
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and consequently
Q0out2
Q0out1
     
      à M   Q
0
in2
Q0 in1
     
      à M  M Qin2Qin1
     
      à M2 Qin2Qin1
     
      Ö25Ü
This example can be easily generalized to the case of a row of n-units. More precisely, we
infer that the lumped parameter model for an n-unit bioreactor, denoted byMn is themultipli-
cative composition of n single unit models, namely
Mn à Mn Ö26Ü
where the latter expression denotes the n-th power of the operatorM.
This approach can be applied to flow (as illustrated above) as well as to mass transport. In
this way, the lumped parameter modelsM,D, derived in section 3.1 for single unit configura-
tions, can be extended to multi-unit configurationsmade of units combined in a row. Using
direct numerical simulations of multi-cell configurations, we will demonstrate in the next sec-
tions the good accuracy of these reducedmodels.
We finally observe that the model composition rule is also applicable in the case of combi-
nation of different unit designs (schematized in Fig 4 with letters A, B, C). In particular, the
input/output relation (Y =M   X) for a row of 3-units of generic typeA, B, C of which we know
the individual lumped parameter models,MA,MB,MC respectively, is given byM =MA  MB  
MC. Following the ambitious vision of building a human-on-chip model, any pattern of biore-
actors organized in a row can be characterized using this approach, provided that the proper-
ties of each individual unit are known.
4 Numerical Simulations
4.1 Numerical simulation of flow
In this study, simulations of flow are performed to compare flow patterns in the GelMA and
PLLA scaffold when inlet flow rates are varied.More precisely, the following different flow
pairs were simulated: (a) 1 and 1, (b) 1 and 2 and (c) 10 and 10 ml/day for the upper and lower
inlet, respectively.
We observe that for all the configurations, the fluid is driven by the pressure gradient to
move toward the upper chamber (Fig 5). The flow split obtained by applying the different flow
pairs are reported in Tables 3 and 4 for the GelMA and PLLA case, respectively. The compari-
son of the outlet flow rates for the two scaffolds highlighted opposite outcomes in terms of flow
mixing. Indeed, while not significant flowmixing was found for the GelMA scaffold, a signifi-
cant mixing occurs in the PLLA case. As expected, the maximummixing (that is 42.9%) occurs
with different input fluid flow rates (1 and 2 ml/day at the upper and lower inlet, respectively).
For the sake of brevity, the results of the 4-units array are not reported since they are the
qualitatively equivalent to the single unit configuration.
4.2 Numerical simulation of transport
Simulations of oxygen transport were performed to compare mass transfer in the GelMA and
PLLA scaffolds.
Concentrations equal to 3.15 and 7.2 μg/l were applied at the upper and lower inlet, respec-
tively. As in the previous case, the following flow pairs were simulated: (a) 1 and 1, (b) 1 and 2
and (c) 10 and 10 ml/day at the upper and lower inlet. Two configurations of the bioreactor
were considered, namely 1-unit and a 4-unit array. The results of 1-unit model are reported in
Fig 6 and Fig 7 for the GelMA and PLLA scaffold, respectively. The analysis of the mass
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transport simulations obtained for the GelMA and the PLLA scaffolds allows us to draw gen-
eral considerations, which are valid for both single and 4-unit arrays.
Firstly, as explained in section 2.3.2, we see that axial advection is dominant with respect to
the cross-wind diffusion. Therefore, the higher the flow rates and fluid velocity, the more the
inlet and outlet oxygen concentrations look similar due to a reduced oxygen drop (Fig 6B and
Fig 7B). However, the diffusion of oxygen from the lower chamber to the upper one is not neg-
ligible, because different inlet concentrations promote the formation of concentration gradients
that trigger transport.
For both the GelMA and PLLA cases, the oxygen concentration in the top region of the scaf-
fold is higher in the case of low flow rate, (a, inlet flow equal to 1 ml/day) than in the case of
high flow rate (c, inlet flow equal to 10 ml/day). Concerning case (b), the mix of the two cham-
bers’ flow is greater and a contribution of convective transport is added to the diffusive flux
Fig 4. Distribute vs lumped parameter models Top: A 8-unit bioreactor configuration, showing details of a 2-unit example used for the development of the
lumped parameter model (top panels). Bottom: A sketch of a multi-unit bioreactor configuration with heterogeneous unit design in a generic sequence of
units, where different unit designs are denoted with letters A, B, C.
doi:10.1371/journal.pone.0162774.g004
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from the bottom towards the top of the bioreactor chamber. For this reason, the oxygen con-
centration in the top region of the scaffold is greater in case (b) than in cases (a) and (c).
Finally, the simulations suggest that the scaffold porosity and permeability play a relevant
role on mass transport. Indeed, while the GelMA is permeable to oxygen, the PLLA is not. This
implies that the aforementioned phenomena are more evident with a polymeric scaffold imper-
vious to mass transport through the solid phase, such as PLLA.
4.3 Oxygen consumption
The simulations of oxygen consumption were performed for the two different scaffolds
(GelMA and PLLA) for an array of 4-units, in order to study the depletion of nutrients in the
culture medium. The flow split is the one of case (a) (1 and 1 ml/day) and the inlets concentra-
tions are equal to 3.15 and 7.2 μg/l at the upper and lower inlet, which correspond to the nor-
moxic levels of the different types of tissue grown in the upper and lower chambers.
Since we consider a 4-unit array, we observe that diffusion develops more easily along the
bioreactor axis (longer fluid path with respect to the 1-unit case) and as a consequence, the
Fig 5. Streamlines in the 1- unit model with the GelMA scaffold.
doi:10.1371/journal.pone.0162774.g005
Table 3. Results obtained by simulating different flow split in the one unit model with the GelMA and PLLA scaffold.
Inlet GelMA PLLA
Qin,top [Kg/s] Qin,down [Kg/s] Qout,top [Kg/s] Qout,down [Kg/s] Qout,top [Kg/s] Qout,down [Kg/s]
a) 1 1 1 1 1.032 0.968
b) 1 2 1 2 1.429 1.571
c) 10 10 10 10 10.32 9.68
doi:10.1371/journal.pone.0162774.t003
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oxygen concentration tends to becomemore uniform.More precisely, enhanced diffusion
combined with different inlet concentrations causes a decrease of the oxygen level in the lower
chamber and an increase in the top one. This trend is heightened by cellular oxygen consump-
tion, which further leads to a diminishing of the oxygen concentration in the lower chamber
(Fig 8).
The two types of scaffold show the same trend of oxygen consumption, but the computa-
tions highlighted different percentage of consumed oxygen. Indeed, a higher percentage of oxy-
gen consumption was found for the PLLA scaffolds with respect to GelMA. This effect is likely
a result of the different cell density used for the two cases. In fact, cell density is assumed to be
equal to 1 x 106 cells/ml for GelMA and to 2.12304019 x 106 cells/ml in the case of PLLA.
4.4 Comparison of distributed and lumped parameter models
In this section, the results of the lumped and the distributed parameter models are presented
and compared in terms of fluid dynamics and mass transport. The fluid dynamics results for
1-unit and 4-units array are first presented, then, the mass transport results of both configura-
tions are studied. For the sake of brevity, we present only the results obtained by simulating the
GelMA scaffold.
4.4.1 Fluid dynamics. Two computational fluid dynamics simulations were performed for
the single unit configuration to determine the lumped parameter model (LPM). In particular,
two inlet flow pairs are applied as reported in Table 5. The resulting LPMmatrix M is:
M à 1 6:820 e  8
6:188 e  8 0:9999
" #
Table 4. Percentage of oxygen consumption for the GelMA and PLLA scaffold.
GelMA PLLA
Upper chamber 0.93% 4.9%
Lower Chamber 1.8% 8.14%
doi:10.1371/journal.pone.0162774.t004
Fig 6. Oxygen concentration with GelMA scaffold. From left to right, flow pair of 1–1 [ml/day], 1–2 [ml/day], 10–10 [ml/
day].
doi:10.1371/journal.pone.0162774.g006
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Then, the results of the 1-unit and 4-unit LPMs are compared to those of the distributed
parameter model, see Tables 6 and 7, and in two test cases the error was lower than 1%.
4.4.2 Mass transport. For the LPMmodel of mass transport we have adopted the parame-
ters of Table 2 and inlet concentrations summarized in Table 8.
To start with, we analyze the mass transport model without cell metabolism, that is the case
S(Cs) = 0 in Eq 5. The LPMmodel for the correspondingmass transport simulations is the fol-
lowing matrix:
D à 0:8481 0:1519
0:1519 0:8481
" #
The results of the 1-unit LPM are compared with those of the distributed parameter model
in two simulations with different inlets concentrations, reported in Table 9, whose values are
Fig 7. Oxygen concentration with PLLA scaffold. From left to right, flow pair of 1–1 [ml/day], 1–2 [ml/day], 10–10 [ml/day].
doi:10.1371/journal.pone.0162774.g007
Fig 8. Oxygen concentration in the 4 cells array. GelMA (left) and PLLA (right) scaffolds are used when with active
consumption rate.
doi:10.1371/journal.pone.0162774.g008
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set according to ongoing experimental tests. The results from the LPMmodel differ from those
of the distributed parameters model by less than the 1%.
We also calculate the LPMmodel for mass transport with active cell metabolism. For the
linear model, S(Cs) = rCs, the LPMmatrix for 1-unit is the following
Dl à
0:6550 0:137
0:137 0:605
" #
while for the Michaelis-Menten case, namely Eqs 11 and 12, the LPMmodel becomes
Dmm à
0:8377 0:1347
0:1327 0:8147
" #
The inspection of the matricesD,Dl,Dmm informs about the characteristics of the different
consumption models compared here. We observe that the diagonal entries of Dl are the small-
est, confirming that the linear model is the one with the highest oxygen consumption rate. The
extra-diagonal coefficients correspond to the oxygen exchange between the upper and lower
chambers. Their magnitude is similar in all cases, because they depend on the diffusion param-
eters solely. For the linear case, the theory at the basis of the LPM derivation is satisfied, while
it does not rigorously hold true for the Michaelis-Menten model, because the mass transport
equation becomes nonlinear. Once again, numerical simulations based on the full model
applied to the 8-unit array confirm that the LPMmodel with linear consumption rate, namely
Dl, predicts outlet concentrations with less than 1% error. The corresponding results are
reported in Table 10 and visualized in Fig 9. In Table 11 we report the error of the LPM based
on the Michaelis-Menten nonlinear consumption rate. Despite the nonlinear nature of the
problem, in conflict with the principles at the basis of the LPM derivation, the LPMmodel is
fairly accurate in predicting the concentration split and decay at the outlet also with a Michae-
lis-Menten consumption rate, with a maximum error of about 10% for an array of 4-units,
located on the bottom outlet of the bioreactor.
The LPMmodel for mass transport is particularly interesting because it allows us to estimate
the decay of nutrient concentrations due to cell metabolism along an arbitrarily long array of
units, using the formula Cout ÖnÜ à Dn   Cin . Considering for example the inlet concentrations
of Table 9, test case #2 for Cin ; we estimate the outlet concentration decay for the transport
model without oxygen consumption. The same calculation is then repeated for the linear and
the Michaelis-Menten models for cell metabolism and the results are compared in Fig 9, where
also the outlet concentrations determined using the fully 3D simulations are shown for a quali-
tative visualization of the LPM error.
Table 5. Simulation settings to identify the fluid dynamics characteristics of one-unit bioreactor.
Qin,top [Kg/s] Qin,down [Kg/s] Qout,top [Kg/s] Qout,down [Kg/s]
#1 1e-08 0 1e-08 6.19e-16
#2 0 1e-08 6.82e-16 9.99e-9
doi:10.1371/journal.pone.0162774.t005
Table 6. Comparison of the 1-unit fluid dynamics results provided by the distributed (distr) and the lumped (lump) parameter models.
Qin,top [Kg/s] Qin,down [Kg/s] Qout,top,distr [Kg/s] Qout,down,distr [Kg/s] Qout,top,lump [Kg/s] Qout,down,lump [Kg/s]
#1 1.157e-08 1.157e-08 1.157e-08 1.157e-08 1.157e-08 1.569e-08
#2 1.157e-08 2.314e-08 1.157e-08 2.314e-08 1.157e-08 2.313e-08
doi:10.1371/journal.pone.0162774.t006
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5 Discussion
From the engineering standpoint, our study shed lights on important aspects of the bioreactor
behavior. We observe that the flow is dominated by viscous effects and by pressure gradients,
while inertial effects are negligible.Differences in inlet velocities between upper and lower
chamber generate a vertical pressure gradient inside the bioreactor chambers, which promotes
mixing of nutrient fluid flowing through the osteochondral construct. Furthermore, we have
observed that the magnitude of vertical pressure gradients depends highly on the permeability
of the scaffold. Between the two materials tested here, it appears that the most permeable one
favors the mixing of fluid among the upper and lower chambers.
Concerningmass transfer, our simulations suggest that it is dominated by convection. Dif-
fusion effects are however non-negligible, but their (relative) intensity varies according to the
inlet flow rate and the scaffold properties.More precisely, Fig 6 and Fig 7 show that high flow
rates decrease the transport of biochemical species between the two chambers. From the analy-
sis of these plots we also observe that the concentration in the bioreactor top chamber is greater
than the one at the upper outlet. This means that the exchange between the chamber and the
supplying channels is not sufficient to remove all the chemical species that accumulate in this
region, because of combined diffusion and convection. This effect is observable for both types
of scaffold, but is more evident for GelMA, suggesting that this type of material hinders flow
and mass transport more than PLLA does.When nutrient (or oxygen) consumption is
switched on in the simulation, concentration gradients are quickly smoothed out when travel-
ing along multiple bioreactor units. At the same time, concentration levels significantly
decrease. The computational model thus serves as a valuable tool to estimate whether the final
units of the row receive enough nutrients, as illustrated in the example presented above.
Finally, we have developed a surrogate, inexpensive approach to characterize the output of
the bioreactor without the burden of runningmany computer simulations. It consists of a
lumped parameter model, derived exploiting the linearity of the full model. The LPM has
proven to be very accurate in capturing the effect of sequentially combining multiple units. A
natural application of this model is studying the concentration decay along a sequence of biore-
actor units. For example, Fig 9 shows the concentration decay at the bioreactor outlets when
the number of units is varied from 1 to 16. Three sets of curves outline the behavior of different
cell metabolismmodels.When cell metabolism is switched off (dashed lines), the upper and
lower concentrations equilibrate very quickly, confirming that diffusion effects of oxygen
between the two chambers are non negligible.We recall that large oxygen diffusion and trans-
port between the upper and lower chambers is not necessarily desirable, when different types
of tissue are grown. Indeed, in our case, cartilage natural environment should be hypoxic, while
Table 7. Comparison of the 4-unit array fluid dynamics results provided by the distributed (distr) and the lumped (lump) parameter models.
Qin,top [Kg/s] Qin,down [Kg/s] Qout,top, distr [Kg/s] Qout,down, distr [Kg/s] Qout,top, lump [Kg/s] Qout,down, lump [Kg/s]
#1 1.157e-08 1.157e-08 1.157e-08 1.157e-08 1.157e-08 1.569e-08
#2 1.157e-08 2.314e-08 1.157e-08 2.314e-08 1.157e-08 2.313e-08
doi:10.1371/journal.pone.0162774.t007
Table 8. Simulation settings to identify the mass transport input-output characteristics of one-unit
bioreactor.
[O2]in,top [mg/ml] [O2]in,down [mg/ml] [O2]out,top [mg/ml] [O2]out,down [mg/ml]
#1 1e-03 0 8.514e-04 1.486e-04
#2 0 1e-03 1.486e-04 8.514e-04
doi:10.1371/journal.pone.0162774.t008
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bone better develops in normoxic conditions. For constant consumption rate, the concentra-
tion decay is the largest. As a consequence after 16 bioreactor units, almost all the nutrient con-
centration has been consumed. The Michaelis-Menten metabolicmodel is the most realistic of
the three options, because it accounts for a saturation effect that limits the consumption rate.
According to our preliminary data on cell viability in the bioreactor, obtained by Live/Dead
assays (data not shown), the oxygenation computed after 16-units appears to be still at a suffi-
cient level.
The computational approach proposed here is subject to some limitations. One is the
approximation of the fluid dynamic and mass transport through steady model. A key challenge
in the engineering of three-dimensional tissue is maintenance of cell viability when the volu-
metric cell density increases. In this study, we assumed a constant cell density equal to the ini-
tial culture conditions that occur after distributing cells homogenously throughout the volume
Table 9. Comparison of the one-unit oxygen concentration results provided by the distributed (distr) and the lumped (lump) parameter models.
[O2]in,top [mg/ml] [O2]in,down [mg/ml] [O2]out,top,distr [mg/ml] [O2]out,down,distr [mg/ml] [O2]out,top,lump [mg/ml] [O2]out,down,lump [mg/ml]
#1 3.15e-03 7.2e-03 3.765e-03 6.585e-03 3.765e-03 6.585e-03
#2 2e-03 4e-03 2.304e-03 3.696e-03 2.304e-03 3.696e-03
doi:10.1371/journal.pone.0162774.t009
Table 10. Comparison of the 8-unit array oxygen concentration results provided by the distributed (distr) and the lumped (lump) parameter mod-
els with linear consumption rate.
[O2]in,top
[mg/ml]
[O2]in,down
[mg/ml]
[O2]out,top, distr
[mg/ml]
[O2]out,down,distr
[mg/ml]
[O2]out,top,lump
[mg/ml]
[O2]out,down,lump
[mg/ml]
#1 3.15e-03 7.2e-03 6.555 e-4 5.628 e-4 6.545 e-4 5.613 e-4
#2 2e-03 4e-03 3.826 e-4 3.274 e-4 3.821 e-4 3.265 e-4
doi:10.1371/journal.pone.0162774.t010
Fig 9. Variation of the outlet concentration of oxygen with respect to the number of units (unit #0 denotes
the inlet value) for the mass transport model without cell metabolism (dashed line), with linear
consumption rate (dotted line) and with Michaelis-Menten consumption model (solid line). Data calculated
using the full 3D model are reported in red.
doi:10.1371/journal.pone.0162774.g009
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of the scaffolds. However, variations in cell density with time could be easily incorporated in
both our models, to predict oxygen drops in long-term culture. Secondly, as literature data are
lacking, we assumed the GelMA properties (i.e., porosity and permeability) equal to those of
native cartilage. Experimental tests will be performed in future work to assess these properties.
Finally, we have not accounted for transport along capillaries. This could be acceptable for
many engineered constructs that are approximation of native tissues, frequently obtained from
single cell types, e.g., mesenchymal stem cells, within a hydrogel or a porous scaffold. If the
HTB were to be used with native tissues, we expect our approach to hold true with the neces-
sary adjustments to account for the different tissues types. The avascular components of carti-
lage would be modeled adjusting the parameters we currently used for GelMA, whereas the for
the vascularizedbone, the more porous structure we described for the PLLA scaffold could
offer a good startingmodel to approximate the cavities and capillaries present in subchondral
bone.
Another improvement of our study would be to validate the oxygen concentration drops
predicted by our models with actual measurements performedwhen the bioreactor is operated
with cell-seeded constructs. This validation would be technically challenging, only feasible
using oxygen sensors incorporated in the perfusion circuit, at the inlet and outlets of each bio-
reactor unit or even inserted directly in the chambers, in direct contact with the living cells
[37]. Detecting larger molecules, even at low concentrations provides a more simple and reli-
able quantification. On this basis, extensive validation of the ability of our models to predict
the flow-dynamics and mass transport in the bioreactor will be the subject of future work.
6 Conclusions and Perspectives
From the methodological standpoint, we have overcome the challenge of developing a complex
multi-physics model of the bioreactor. We have also succeeded in implementing the model
into a commercial computational platform, showing the significant potential of computational
tools on biomedical research, including analytical cases integrating quantitative biology and
translational medicine. Future developments of this study consist of experimental validation of
the models and their application to explore different bioreactor configurations. Such findings
will allow optimization of the model by incorporating the multi-faceted factors that affect its
behavior and functionality.
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